Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients

NCT01808261 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01808261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01808261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study MAG104615, a Proof of Concept Study for GSK249320 Versus Placebo in Stroke Patients
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Terminated
Start date
May 18, 2013
Completion date
July 28, 2014
Enrollment
134 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident